# Naureen Starling

Source: https://onco.cc/people/naureen-starling/  
OnCo record `naureen-starling` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The Royal Marsden oncologist who runs the UK trial testing whether a blood test for leftover tumour DNA can decide who needs chemotherapy after bowel cancer surgery.

## Summary

Naureen Starling is a consultant medical oncologist at The Royal Marsden specialising in gastrointestinal cancers, director of the Royal Marsden Clinical Trials Unit and a reader in the Division of Clinical Studies at the Institute of Cancer Research; she is training programme director for medical oncology and chairs the pan-London specialist training committee. She is a senior author on the TRACC Part B analysis, which showed that a tissue-free assay combining genomic and methylation signals can detect minimal residual disease after surgery for early colorectal cancer across a UK multicentre cohort.

## Fields

- Kind: Person
- Last checked: 2026-09-24
- Tags: colorectal; trialist; uk
- Role: Consultant Medical Oncologist and Director of the Clinical Trials Unit, The Royal Marsden; Reader, The Institute of Cancer Research
- Specialisms: Gastrointestinal cancer; Circulating tumour DNA; Early-phase and translational trials

## Sources

- The Royal Marsden consultant directory: https://www.royalmarsden.nhs.uk/our-consultants-units-and-wards/consultant-directory/naureen-starling

## Connected records

- people: [Ian Chau](https://onco.cc/people/ian-chau/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- institutions: [The Institute of Cancer Research](https://onco.cc/institutions/icr-london/), [The Royal Marsden](https://onco.cc/institutions/royal-marsden/)
- trials: [TRACC](https://onco.cc/trials/tracc/)

---
JSON: https://onco.cc/api/v1/entities/naureen-starling.json